BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24520096)

  • 21. COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
    Majumder M; Landman E; Liu L; Hess D; Lala PK
    Mol Cancer Res; 2015 Jun; 13(6):1022-33. PubMed ID: 25733698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling pathway.
    Xiang Y; Ye W; Huang C; Lou B; Zhang J; Yu D; Huang X; Chen B; Zhou M
    Biochem Biophys Res Commun; 2017 Jun; 487(4):820-826. PubMed ID: 28455228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel natural product, britanin, inhibits tumor growth of pancreatic cancer by suppressing nuclear factor-κB activation.
    Li K; Zhou Y; Chen Y; Zhou L; Liang J
    Cancer Chemother Pharmacol; 2020 Apr; 85(4):699-709. PubMed ID: 32185482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-κB pathway.
    Lee KC; Chang HH; Chung YH; Lee TY
    J Ethnopharmacol; 2011 Jun; 135(3):678-84. PubMed ID: 21497192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altholactone Inhibits NF-κB and STAT3 Activation and Induces Reactive Oxygen Species-Mediated Apoptosis in Prostate Cancer DU145 Cells.
    Jiang C; Masood M; Rasul A; Wei W; Wang Y; Ali M; Mustaqeem M; Li J; Li X
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28178219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
    Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
    Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells.
    Veeraraghavan J; Natarajan M; Lagisetty P; Awasthi V; Herman TS; Aravindan N
    Pancreas; 2011 Oct; 40(7):1107-19. PubMed ID: 21697760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
    Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
    Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B
    J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB.
    Murtaza I; Adhami VM; Hafeez BB; Saleem M; Mukhtar H
    Int J Cancer; 2009 Nov; 125(10):2465-73. PubMed ID: 19670328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis and G2/M cell cycle arrest induced by a timosaponin A3 from Anemarrhena asphodeloides Bunge on AsPC-1 pancreatic cancer cells.
    Kim Y; Kim KH; Lee IS; Park JY; Na YC; Chung WS; Jang HJ
    Phytomedicine; 2019 Mar; 56():48-56. PubMed ID: 30668353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.
    Kim HR; Park CG; Jung JY
    Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Small Molecular Prostaglandin Receptor EP4 Antagonist, L001, Suppresses Pancreatic Cancer Metastasis.
    He J; Lin X; Meng F; Zhao Y; Wang W; Zhang Y; Chai X; Zhang Y; Yu W; Yang J; Li G; Du X; Zhang H; Liu M; Lu W
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35208999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.
    Radhakrishnan P; Bryant VC; Blowers EC; Rajule RN; Gautam N; Anwar MM; Mohr AM; Grandgenett PM; Bunt SK; Arnst JL; Lele SM; Alnouti Y; Hollingsworth MA; Natarajan A
    Clin Cancer Res; 2013 Apr; 19(8):2025-35. PubMed ID: 23444213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Celecoxib suppresses proliferation and metastasis of pancreatic cancer cells by down-regulating STAT3 / NF-kB and L1CAM activities.
    Zuo C; Hong Y; Qiu X; Yang D; Liu N; Sheng X; Zhou K; Tang B; Xiong S; Ma M; Liu Z
    Pancreatology; 2018 Apr; 18(3):328-333. PubMed ID: 29525378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine.
    Ghosh R; Garcia GE; Crosby K; Inoue H; Thompson IM; Troyer DA; Kumar AP
    Neoplasia; 2007 Nov; 9(11):893-9. PubMed ID: 18030357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chrysoeriol ameliorates TPA-induced acute skin inflammation in mice and inhibits NF-κB and STAT3 pathways.
    Wu JY; Chen YJ; Bai L; Liu YX; Fu XQ; Zhu PL; Li JK; Chou JY; Yin CL; Wang YP; Bai JX; Wu Y; Wu ZZ; Yu ZL
    Phytomedicine; 2020 Mar; 68():153173. PubMed ID: 31999977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of EP2/EP4 signaling abrogates IGF-1R-mediated cancer cell growth: involvement of protein kinase C-θ activation.
    Takahashi T; Uehara H; Ogawa H; Umemoto H; Bando Y; Izumi K
    Oncotarget; 2015 Mar; 6(7):4829-44. PubMed ID: 25638159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
    Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
    Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.